Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maria Claudia Perez

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
Clinical Pediatrics|May 11, 2018
Unmet Needs in Pediatric Functional ConstipationManu Sood, Peter Lichtlen, Maria Claudia Perez
Journal of Pediatric Gastroenterology and Nutrition|July 1, 2011
Pharmacokinetics and safety of dexlansoprazole MR in adolescents with symptomatic GERDMichael Kukulka, Jingtao Wu, Maria Claudia Perez
Clinical and Experimental Gastroenterology|October 17, 2018
Bioavailability of dexlansoprazole delayed-release capsule granules when administered via nasogastric tube or orally via syringeMichael Kukulka, Sai Nudurupati, Maria Claudia Perez
Therapeutic Advances in Gastroenterology|November 3, 2016
Bioavailability, safety, and pharmacodynamics of delayed-release dexlansoprazole administered as two 30 mg orally disintegrating tablets or one 60 mg capsuleMichael Kukulka, Sai Nudurupati, Maria Claudia Perez
Therapeutic Advances in Gastroenterology|November 3, 2016
Pharmacokinetics and pharmacodynamics of an orally disintegrating tablet formulation of dexlansoprazoleMichael Kukulka, Sai Nudurupati, Maria Claudia Perez
Clinical and Experimental Gastroenterology|March 4, 2017
Bioavailability of a dexlansoprazole delayed-release orally disintegrating tablet: effects of food and mode of administrationMichael Kukulka, Sai Nudurupati, Maria Claudia Perez
Clinical and Experimental Gastroenterology|December 20, 2014
Pharmacokinetics and safety of dexlansoprazole MR in pediatric patients with symptomatic gastroesophageal reflux diseaseMichael Kukulka, Sai Nudurupati, Maria Claudia Perez
Gastroenterology|July 2, 2019
ReplyJeri W Nieves, Maria Claudia Perez, David C Metz, et al.
Endocrine Reviews|April 29, 2005
Selective progesterone receptor modulator development and use in the treatment of leiomyomata and endometriosisKristof Chwalisz, Maria Claudia Perez, Deborah Demanno, et al.
Gastroenterology|November 17, 2018
Dexlansoprazole and Esomeprazole Do Not Affect Bone Homeostasis in Healthy Postmenopausal WomenKaren E Hansen, Jeri W Nieves, Sai Nudurupati, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Clinical Pediatrics|May 11, 2018
Unmet Needs in Pediatric Functional ConstipationManu Sood, Peter Lichtlen, Maria Claudia Perez
Journal of Pediatric Gastroenterology and Nutrition|July 1, 2011
Pharmacokinetics and safety of dexlansoprazole MR in adolescents with symptomatic GERDMichael Kukulka, Jingtao Wu, Maria Claudia Perez
Clinical and Experimental Gastroenterology|October 17, 2018
Bioavailability of dexlansoprazole delayed-release capsule granules when administered via nasogastric tube or orally via syringeMichael Kukulka, Sai Nudurupati, Maria Claudia Perez
Therapeutic Advances in Gastroenterology|November 3, 2016
Bioavailability, safety, and pharmacodynamics of delayed-release dexlansoprazole administered as two 30 mg orally disintegrating tablets or one 60 mg capsuleMichael Kukulka, Sai Nudurupati, Maria Claudia Perez
Therapeutic Advances in Gastroenterology|November 3, 2016
Pharmacokinetics and pharmacodynamics of an orally disintegrating tablet formulation of dexlansoprazoleMichael Kukulka, Sai Nudurupati, Maria Claudia Perez
Clinical and Experimental Gastroenterology|March 4, 2017
Bioavailability of a dexlansoprazole delayed-release orally disintegrating tablet: effects of food and mode of administrationMichael Kukulka, Sai Nudurupati, Maria Claudia Perez
Clinical and Experimental Gastroenterology|December 20, 2014
Pharmacokinetics and safety of dexlansoprazole MR in pediatric patients with symptomatic gastroesophageal reflux diseaseMichael Kukulka, Sai Nudurupati, Maria Claudia Perez
Gastroenterology|July 2, 2019
ReplyJeri W Nieves, Maria Claudia Perez, David C Metz, et al.
Endocrine Reviews|April 29, 2005
Selective progesterone receptor modulator development and use in the treatment of leiomyomata and endometriosisKristof Chwalisz, Maria Claudia Perez, Deborah Demanno, et al.
Gastroenterology|November 17, 2018
Dexlansoprazole and Esomeprazole Do Not Affect Bone Homeostasis in Healthy Postmenopausal WomenKaren E Hansen, Jeri W Nieves, Sai Nudurupati, et al.
Pageof 2